Iolanda Riba-Llena
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Iolanda Riba-Llena has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Joan Montaner
Stroke Unit, Department of Neurology, Hospital Universitario Virgen Macarena, Sevilla, Spain (S.P.S., J. Montaner, A.S.B.).
3 shared publications - Pilar Delgado
Department of Neurology, Hospital Universitari de la Vall d’Hebrón, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain
3 shared publications Olga Maisterra
Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, Neurovascular Research Lab, Barcelona, Spain
2 shared publications- Alejandra Planas
Diabetes Research and Metabolism Unit. Vall d'Hebron Institute of Research (VHIR), Vall d'Hebron University Hospital, Barcelona, Spain
1 shared publication - Alejandro Bustamante
Stroke Unit, Department of Neurology, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona , Badalona
1 shared publication - Alex Ferré
Department of Clinical Neurophysiology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain; Multidisciplinary Sleep Unit, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain
1 shared publication
Latest Publications
- 7 November 2023
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 33 (1) , 107467
Common and specific proteins and pathways in heart and cerebral ischemia
- 7 November 2023
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 33 (1) , 107467
Common and specific proteins and pathways in heart and cerebral ischemia
- 1 February 2020
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 409, 116635
Kidney function changes and their relation with the progression of cerebral small vessel disease and cognitive decline
- 1 February 2020
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 409, 116635
Kidney function changes and their relation with the progression of cerebral small vessel disease and cognitive decline
- 13 January 2020
- Published by Springer Nature in Journal of Clinical Sleep Medicine
- Vol. 16 (2) , 243-250
Nighttime hypoxia affects global cognition, memory, and executive function in community-dwelling individuals with hypertension
Study Objectives:The objective of this study was to determine which respiratory and architectural sleep parameters are related to cognitive function and cognitive status (mild cognitive impairment ...
- 13 January 2020
- Published by Springer Nature in Journal of Clinical Sleep Medicine
- Vol. 16 (2) , 243-250
Nighttime hypoxia affects global cognition, memory, and executive function in community-dwelling individuals with hypertension
Study Objectives:The objective of this study was to determine which respiratory and architectural sleep parameters are related to cognitive function and cognitive status (mild cognitive impairment ...
- Open Access
- 2 October 2013
- Published by Springer Nature in BMC Neurology
- Vol. 13 (1) , 1-8
Investigating silent strokes in hypertensives: a magnetic resonance imaging study (ISSYS): rationale and protocol design
Background: Silent brain infarcts are detected by neuroimaging in up to 20% of asymptomatic patients based on population studies. They are five times more frequent than stroke in general population, and increase significantly both with advancing age and hypertension. Moreover, they are independently associated with the risk of future stroke and cognitive decline. Despite these numbers and the clinical consequences of silent brain infarcts, their prevalence in Mediterranean populations is not well known and their role as predictors of future cerebrovascular and cardiovascular events in hypertensive remains to be determined. ISSYS (Investigating Silent Strokes in Hypertensives: a magnetic resonance imaging study) is an observational cross-sectional and longitudinal study aimed to: 1- determine the prevalence of silent cerebrovascular infarcts in a large cohort of 1000 hypertensives and to study their associated factors and 2-to study their relationship with the risk of future stroke and cognitive decline. Methods/Design: Cohort study in a randomly selected sample of 1000 participants, hypertensive aged 50 to 70 years old, with no history of previous stroke or dementia. On baseline all participants will undergo a brain MRI to determine the presence of brain infarcts and other cerebrovascular lesions (brain microbleeds, white matter changes and enlarged perivascular spaces) and will be also tested to determine other than brain organ damage (heart-left ventricular hypertrophy, kidney-urine albumin to creatinine ratio, vessels-pulse wave velocity, ankle brachial index), in order to establish the contribution of other subclinical conditions to the risk of further vascular events. Several sub-studies assessing the role of 24 hour ambulatory BP monitoring and plasma or genetic biomarkers will be performed. Follow-up will last for at least 3 years, to assess the rate of further stroke/transient ischemic attack, other cardiovascular events and cognitive decline, and their predictors. Discussion: Improving the knowledge on the frequency and determinants of these lesions in our setting might help in the future to optimize treatments or establish new preventive strategies to minimize clinical and socioeconomic consequences of stroke and cognitive decline.
- 2 October 2013
- Published by Springer Nature in BMC Neurology
- Vol. 13 (1) , 1-8
Open AccessInvestigating silent strokes in hypertensives: a magnetic resonance imaging study (ISSYS): rationale and protocol design
Background: Silent brain infarcts are detected by neuroimaging in up to 20% of asymptomatic patients based on population studies. They are five times more frequent than stroke in general population, and increase significantly both with advancing age and hypertension. Moreover, they are independently associated with the risk of future stroke and cognitive decline. Despite these numbers and the clinical consequences of silent brain infarcts, their prevalence in Mediterranean populations is not well known and their role as predictors of future cerebrovascular and cardiovascular events in hypertensive remains to be determined. ISSYS (Investigating Silent Strokes in Hypertensives: a magnetic resonance imaging study) is an observational cross-sectional and longitudinal study aimed to: 1- determine the prevalence of silent cerebrovascular infarcts in a large cohort of 1000 hypertensives and to study their associated factors and 2-to study their relationship with the risk of future stroke and cognitive decline. Methods/Design: Cohort study in a randomly selected sample of 1000 participants, hypertensive aged 50 to 70 years old, with no history of previous stroke or dementia. On baseline all participants will undergo a brain MRI to determine the presence of brain infarcts and other cerebrovascular lesions (brain microbleeds, white matter changes and enlarged perivascular spaces) and will be also tested to determine other than brain organ damage (heart-left ventricular hypertrophy, kidney-urine albumin to creatinine ratio, vessels-pulse wave velocity, ankle brachial index), in order to establish the contribution of other subclinical conditions to the risk of further vascular events. Several sub-studies assessing the role of 24 hour ambulatory BP monitoring and plasma or genetic biomarkers will be performed. Follow-up will last for at least 3 years, to assess the rate of further stroke/transient ischemic attack, other cardiovascular events and cognitive decline, and their predictors. Discussion: Improving the knowledge on the frequency and determinants of these lesions in our setting might help in the future to optimize treatments or establish new preventive strategies to minimize clinical and socioeconomic consequences of stroke and cognitive decline.